Back
Rexford Industrial Realty, Inc. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Sell
31
REXR
Rexford Industrial Realty, Inc.
Last Price:
$40.36
Seasonality Move:
0%
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
31
Rexford Industrial Realty, Inc. (REXR)
is a Sell
Is Rexford Industrial Realty, Inc. a Buy, Sell or Hold?
-
The current Rexford Industrial Realty, Inc. [REXR] share price is $40.36. The Score for REXR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
REXR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
REXR Stock Price Chart
What is Rexford Industrial Realty, Inc.'s stock price today?
-
The Rexford Industrial Realty, Inc. share price today is $40.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REXR is experiencing selling pressure, which indicates risk of future bearish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $31.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
REXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.08 | Buy |
| Relative Strength Index (14 RSI): | 44.26 | Sell |
| Chaikin Money Flow: | -1401789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.36 - 41.48) | Sell |
| Bollinger Bands (100): | (39.2 - 42.72) | Sell |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 394649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.23 - 31.09) | Buy |
| Bollinger Bands (100): | (15.89 - 28.91) | Buy |
REXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.05 | Sell |
| 20-day SMA: | 41.02 | Sell |
| 50-day SMA: | 41.46 | Sell |
| 200-day SMA: | 38.54 | Buy |
| 8-day EMA: | 25.89 | Buy |
| 20-day EMA: | 13.49 | Buy |
| 50-day EMA: | 6.05 | Buy |
| 200-day EMA: | 1.6 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.97 | Buy |
| 20-day SMA: | 30.06 | Buy |
| 50-day SMA: | 28.52 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 30.34 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 21.05 | Buy |
Rexford Industrial Realty, Inc. Earnings Growth & REXR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.17 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
Rexford Industrial Realty, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||